Abstracts presented by CRF

PUBLISHED ABSTRACTS:   

 

·                     Apte K, Barne M, Madas S, Gogtay J, Chhowala S, Salvi S. Number of Tuberculosis (TB) cases reported by Primary Care Physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India. Eur Respir J 2013.

 

·                     Kodgule R, Vanjare N, Rasam S, Bhosale S, Gupta Y, Salvi S. Can Impulse Oscillometry and Body Plethysmography differentiate response to two salbutamol doses? Eur Respir J 2013.

·                     Kodgule R, Vanjare N, Rasam S, Bhosale S, Gupta Y, Salvi S. Correlation of spirometry with impulse oscillometry, body plethysmography and DLCO. Eur Respir J 2013. Eur Respir J 2013.

·                     Nitin V, Kodgule R, Rasam S, Bhosale S, Gupta Y, Salvi S. Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and C OPD subjects. Eur Respir J 2013.

 

·                     Nitin V, Kodgule R, Rasam S, Bhosale S, Gupta Y, Salvi S. Repeatability and reproducibility of Impulse Oscillometry and Body Plethysmography in healthy, asthmatic and C OPD subjects. Eur Respir J 2013.

 

·                     Kodgule R, Nitin V, Madas S, Chhowala S, Gogtay J, Salvi S. Spirometry use in primary-care & uncertainty of its predicted values in India. Eur Respir J 2013.

 

·                     Vanjare N, Chhowala S, Kodgule R, Madas S, Gogtay J, Salvi S. Has the use of Spirometry improved in India? Results of nationwide studies conducted among chest and primary care physicians between 2005 and 2013. Eur Respir J 2013.

 

·                     Londhe J, Brashier B, Iyer N, Madas S, Juvekar S, Salvi S, Barnes PJ. C omparison of quality of life in smoking and non-smoking C OPD patients in India using St. George's respiratory questionnaire and C OPD assessment test. Eur Respir J 2013.

·                     Madas S, Apte K, Barne M, bhosale S, Gogtay J, Chhowala S, Salvi S. What are the symptoms and diseases for which a child / adolescent visits a primary care physician in India? Result of a 1- day point prevalence study in 65,979 patients from India. Eur Respir J 2013.

·                     Rafiei S, Kulkarni MV, Naik SS, Salvi S, Barnes PJ, Madas S, Iyer N, Brashier B. Phenotypic comparison of glucose and cardiac physiology of Biomass fuel induced and Smoking induced COPD. Eur Respir J 2013.

·                     Iyer N, Brashier B, Madas S, Londhe J, Salvi S, Barnes PJ. Physiological and inflammatory phenotypic comparisons between non-smoking and smoking COPD. Eur Respir J 2013.

·                     Madas S, Apte K, Barne M, Harangule S, Gogtay J, Chhowala S,Mahajan N, Salvi S. Association between COPD and other co-morbid conditions – Results from a 1-day point-prevalence study in 2,04,912 patients from 860 cities & towns in India. Eur Respir J 2012.P 3223.

·                     Iyer N, Kodgule R, Shaik M, Harangule S, Madas S, Salvi S, Brashier S et al. Correlation between sputum cytology and lung physiology in asthma and COPD subjects in Indian population. Eur Respir J 2012, P 2226.

·                     Apte K, Barne M, Madas S, Gogtay J, Chhowala S, Mahajan N, Salvi S. Obstrutive Airway Diseases (OADs) are the most common disease for a Doctor in India – A one day point-prevalence study in 2,04,912 patients from 860 cities & towns in India. Eur Respir J 2012, P 4755.

 

·                     Apte K, Barne M, Madas S, Gogtay J, Chhowala S, Mahajan N, Salvi S. More than 50% of patients visit a general practitioner (GP), general physician (Gen P) or a paediatrician (P) in India for Respiratory symptoms : A one day point-prevalence study in 2,04,912 patients from 860 cities & towns in India. Eur Respir J 2012, P 4343.

 

·                     Apte K, Barne M, Madas S, Gogtay J, Chhowala S, Pachisia B, Salvi S.Presence of Hyper Tension (HT), Ischemic Heart Disease (IHT) and a family history of hypertension and independently associated with Reduced Peak Expiratory Flow (PEF) values. Eur Respir J 2012. P 4010.

·                     Brashier B, Kajale S,  Kodgule R, Londhe J, Madas S, Barnes PJ, Shetty D,  Salvi S. High Resolution CT Scan (HRCT)thorax differences between biomass-smoke exposure induced COPD (BM-COPD) and tobacco smoking COPD (TS- COPD). Eur Respir J 2012, P 268.

·                     Brashier B, Vanjare N, Londhe J, S Madas, Juvekar S, Salvi S, Barnes PJ. Comparison of airway cellular and mediator profiles between tobacco smoke-induced COPD and biomass fuel exposure-induced COPD in an Indian Population. Eur Respir J 2011. P 734.

·                     Brashier B, Vanjare N, V Vincent, Londhe J, Madas S, Juvekar S, Barnes PJ, Salvi S. Lung Function differences in subjects with tobacco smoke-induced COPD (TS-COPD) and biomass smoke-induced COPD (BS-COPD) in an Indian population. Eur Respir J 2011. P 918.

·                     Barne M, Apte K, Chhowala S, Pachisia B, Brashier B, Madas S, Gogtay J, Salvi S. Comparison between presence of respiratory symptoms and Peak Expiratory Flow (PEF) values<80% predicted as screening tools for Obstructive Airways Diseases (OAD). Eur Respir J 2011. P 917.

 

·                     Barne M, Apte K, Chhowala S, Pachisia B, Brashier B, Madas S, Gogtay J, Salvi S. Prevalence of respiratory symptoms in 7154 state road transport workers from India. Eur Respir J 2011. P 4192

 

·                     Kodgule R, Singh V, Bodigovinda S, Dhar R, Londhe J, Brashier B, Singh U, Hafiz U, Mukherjee S, Madas S, Salvi S, Koul P. Derivation of a predicted equation for peak Expiratory Flow (PEF) Values in adult Indian population using EU Scale Peak Flow Meter (PFM). Eur Respir J 2011. P 183.

·                     Salvi S, Juvekar S, Londhe J, Brashier B, Madas S, Barnes PJ. Prevalence of COPD in a rural population in India. Eur Respir J 2011.  P 2954.

·                     Mukkannawar U, Shabhudas S, Juvekar S, Ozha A, Salvi S. Indoor PM2.5 levels in homes using different types of cooking fuels in a rural Indian population and it's association with COPD. Eur Respir J 201,  P 1033.

·                     Muralidharan V, Salvi S, Shambhudas S, Ingole V, Barnes PJ. Spatial distribution of COPD in a rural population in India using geographic information system (GIS). Eur Respir J 2011. P 1004.

·                     R. Kodgule, S. Kapoor, R. Pawar, N. Vanjare, K. Gaikwad, S. Salvi, B. Brashier. Paracetamol increases airway resistance in stable asthmatics: A double blind, randomized, placebo controlled study. Eur Respir J 2010; P3872.

·                     J. Londhe, B. Brashier, S. Hirve, S. Juvekar, S. Salvi. Feasibility of conducting a COPD prevalence study using local field workers. Eur Respir J 2010; P3978

·                     M. Barne, M. Singh, K. Gaikwad, S. Chhowala, J. Gogtay, S. Salvi. Reasons for underutilization of spirometry by practicing physicians in India. Eur Respir J 2010; P4242.

·                     M. Cheraghi, S. Valsa, S. Salvi.  Development of an asthma risk score for childhood asthma in Pune City, India. Eur Respir J 2010; P4815.

·                     S. Salvi, T. Khansamrong, S. Madas. Prevalence of COPD by different types of cooking fuel between India and Thailand.  Eur Respir J 2010; P2570.

·                      R. Balakrishnan, B. Brashier, S. Salvi, K. Gaikwad, S. Sharma, S. Rajan. High prevalence of undiagnosed moderate-to-severe COPD in subjects visiting a tertiary care hospital for a routine medical check. Eur Respir J 2010; P2813.

·                     M. Barne, M. Singh, K. Gaikwad, S. Chhowala, J. Gogtay, S. Salvi. To investigate the perceived need for trained spirometry technicians in India. Eur Respir J 2010; P2872.

·                     S. Kapoor, B. Brashier, A. Udupa, R. Pawar, R. Kodgule, S. Limaye, S. Madas, P. Pandit, B. B. Ghongane, S. Salvi. Therapeutic effect of low dose roxithromycin in chronic stable mild-to-moderate asthma. Eur Respir J 2010; P1176.

·                     R. Kadam, B. Brashier, R. Shetty, S. Salvi. Use of indigenously designed online spirometry quality assessment system in multi-centric clinical trials in India. Eur Respir J 2010; P2831.

·                     S. Limaye, R. Kodgule, S. Raskar, A. Shaikh, V. vincent, K. Gaikwad, S. Salvi.
Single dose of of tiotropium bromide (18 mcg) produces a similar bronchodilator response as two doses of formoterol fumarate (12 mcg ) over 24 hours in subjects with moderate-to-severe asthma
. Eur Respir J 2010; P1193.

·                     S. Salvi, T. Khansamrong, S. Madas. Differential respiratory symptoms between Indian and Thai women using different types of cooking fuel. Eur Respir J 2010; P1408.

·                     Salvi S, Bhonsale K, Brashier B, Limaye S, Mandrekar S, Gaikwad S, Ghorpade SV.  Eight weeks of treatment with tiotropium plus fluticasone (T+F) produces an equally effective therapeutic response as salmeterol plus fluticasone (S+F) in subjects with moderate-to-severe asthma. Eur Respir J 2009; P24s.

·                     Brashier B, Londhe L, Madas S, Salvi S. Prevalence of non-smoking COPD phenotypes in the slum dwellers.  Eur Respir J 2009; P163s.

·                     Limaye S, Zarrabi L, Valsa S, Salvi S. Foreign students who smoke show a significant worsening of lung function within six months of their stay in Pune city, India. Eur Respir J 2009; P199s.

·                     Limaye S, Yeravdekar R, Tilak V, Bhide V, Vincent V, Salvi S. Derivation of the predicted equation for peak inspiratory flow rate (PIFR) for children aged 4-15yrs in an Indian population. Eur Respir J 2009; P203s.

·                     Limaye S, Yeravdekar R, Tilak V, Bhide D, Madas S, Shaikh A, Raskar S, Vincent V, Salvi S. Prevalence of respiratory symptoms and food allergies amongst school children in Pune city, India. Eur Respir J 2009; P253s.

·                     Limaye S, Yeravdekar R, Tilak V, Bhide D, Raskar S, S. Salvi. Derivation of the predicted equation for peak expiratory flow rate (PEFR) for children aged 4-15 years using the new European union (EU) scale peak flow meter (PFM) in an Indian population. Eur Respir J 2009; P273s.

·                     Brashier B, Ravindaran L, Kapoor S, Deshpande PK, Ghongane B, Madas S, Mandrekar S, Limaye S, Salvi S. Four weeks of treatment with N-acetyl cysteine (NAC) (1200mg/day) reduces lung oxidative stress and improves lung function in moderate-to-severe COPD subjects. Eur Respir J 2009; P340s.

·                     Naik S, Salvi S, Brashier B, Phadtare J, Gogtay J, Lulla A, Po J, Purandare S, Sule A. Evaluation of the bronchoprotective effects of salmetrol HFA and salmetrol CFC in adult patients with chronic stable mild to moderate asthma. Eur Respir J 2009; P711s.

·                     Cheraghi M, Madas S, Salvi S. Increased prevalence of childhood asthma in Pune city, India. Eur Respir J 2009; P728s.

·                     Cheraghi M, Brashier B, Madas S, Salvi S. Risk factors for childhood asthma in Pune city.  Eur Respir J 2009; P728s.

·                     Cheraghi M, Brashier B, Madas S, Salvi S. Prevalence of and risk factors associated with dry cough at night (DCN) amongst school children in Pune city, India.  Eur Respir J 2009; P728s.

·                    B. Brashier, D. Kekan, A. Bamnikar, D. Kolte, M. Dhakar, A. Kessari, S. Valsa, S. Mandrekar, S. Limaye, S. Salvi. High prevalence of poorly controlled asthma amongst patients visiting clinics in Pune City, India. Eur Respir J 2008; P221.

·                    S. Saboo, D. Christopher, A. Mesquita, V. Singh, S. Salvi, M. Shete, J. Po, S. Chachad, S. Purandare, A. Lulla, A. Sule. Non-inferiority comparison of budesonide HFA (BUD-HFA) pMDI with budesonide CFC (BUD-CFC) pMDI in patients with persistent moderate asthma. Eur Respir J 2008; P234.

·                    B. Brashier, A. Shaikh, J. Mandale, V. Vincent, S. Raskar, S. Valsa, P. Mahadik, J. Gogtay, S. Salvi. Bronchodilator response of single dose of tiotropium (Tio) plus formoterol (Formo) versus four doses of ipratopium (Ipra) plus salbutamol (Salb) over 24 hours in subjects with moderate-to-severe stable COPD. Eur Respir J 2008; P3496.

·                    P. Niphadkar, J. Joshi, P. A. Mahesh, V. Singh, S. Salvi, Ghosh, A. Athavale, K. A. Satish, P. Mahadik, J. Gogtay. Randomized double blind comparison of ciclesonide-formoterol combination inhaler and ciclesonide alone in persistent asthma. Eur Respir J 2008; P4278

·                    N. Abhyankar, S. Salvi. Prevalence of COPD with reversible obstruction in first spirometries, among patients with obstructive airways disease in western Maharashtra, India. Eur Respir J 2008; P456.

·                    B. Brashier, N. Patel, S. Valsa, S. Mandrekar, S. Kulkarni, S. N. Gaikwad, S. V. Ghorpade, S. Salvi: Respiratory issues in primary care - Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT).  Eur Respir J 2007; P831.

·                    S. Mandrekar, S. Hake, B. Brashier, S. Valsa, S. Salvi: Respiratory issues in primary care - Peak expiratory flow (PEF) values obtained by the new eu scale (en 13826) wrights peak flow meter is comparable to those obtained by a pneumotach and turbine-based spirometer. Eur Respir J 2007; P839.

·                    S. Mandrekar, S. Iyer, S. Kondhalkar, P. Ram, K. Satbhai, R. Ravindran, B. Brashier, S. Valsa, A. Ojha, S. Salvi: Aetiology, mechanisms and treatment in lower respiratory tract infections - Prevalence of respiratory tract infections (RTIS) and its association with ambient particulate matter pollution in an urban city in India. Eur Respir J 2007; P2397.

·                    B. Brashier, S. Gangavane, S. Valsa, S. N. Gaikwad, S. V. Ghorpade, S. Mandrekar, S. Salvi: Epidemiological and clinical aspects of tuberculosis control Almost half the patients treated for pulmonary tuberculosis (TB) show evidence of obstructive airways disease (OAD). Eur Respir J 2007; E 2585.

·                    S. Salvi, M. Singh, B. Brashier, S. Valsa, B. Ghongane, P. Deshpande, D. Nandal Acute and chronic effects of air pollution - Bus drivers supplemented with the anti-oxidant, n-acetyl cysteine (NAC) for 4 weeks show reduced lung oxidative stress and improved lung function. Eur Respir J 2007; E2782.

·                    S. Salvi, M. Singh, B. Brashier, S. Valsa, B. Ghongane, P. Deshpande, D. Nandal; What's new in air pollution from experiments to epidemiology - Fireworks during Diwali festival have a significant impact on respiratory health: a study from India. Eur Respir J 2007; 2942.

·                    S. Mandrekar, S. Siddiq, M. Modak, S. Sunil, S. Valsa, B. Brashier, S. Salvi; Mechanisms of asthma and allergy in young children - Homes of asthmatic children show greater amounts of airborne fungi as compared to homes of non-asthmatic children. Eur Respir J 2007; P 3768.

·                    B. Brashier, S. Saoji, A. Raghupati, S. Mandrekar, S. Valsa, S. N. Gaikwad, S. V. Ghorpade, S. Salvi; Primary care respiratory problems - Correlation between spirometric indices (FEV1, fvc) and lung diffusion values (dlco) in subjects with varying severity of chronic obstructive pulmonary disease (COPD). Eur Respir J 2007; E 4053.

·                    V. Singh, S. S. Salvi, B. B. Brashier, A. U. Athavale, V. B. Murali Mohan, P. S. Bhattacharya, P. M. Gokhale, P. A. Mahadik, J. A. Gogtay: Recent update on Asthma treatment Once daily ciclesonide delivered via pMDI is effective and safe for the treatment of mild-to-moderate persistent asthma.  Eur Respir J 2006; P831.

·                    S. D. Hake, B. B. Brashier, S. V. Valsa, J. A. Gogtay, S. S. Salvi: Airway regulation, provocation and monitoring II - Once daily ciclesonide delivered via pMDI is effective and safe for the treatment of mild-to-moderate persistent Asthma.  Eur Respir J 2006; P1310.

·                    B. B. Brashier, J. D. Londhe, A. M. Jantikar, S. D. Hake, S. N. Valsa, S. S. Salvi: Asthma and allergy: prevalence, incidence and risk factors - Chronic respiratory illnesses in 4953 urban slum children from Pune City. Eur Respir J 2006; P1413.

·                    B. Brashier, J. S. Mandale, V. Vincent, A. Raghupati, S. D. Valsa, S. S. Salvi: Recent advances in asthma treatment - Bronchodilator responses of a cup of tea in asthmatic subjects.  Eur Respir J 2006: P1805.

·                    S. S. Salvi, R. Kesarwani, A. Raghupathy, B. B. Brashier, S. Valsa, S. Gaikwad, D. R. Joshi, S. V. Ghorpade : The challenges of managing asthma in primary care - Medical personnel ability to use pressurized metered dose inhaler (pMDI). Eur Respir J 2006; P 3366.

·                     P. Das, B. B. Brashier, S. V. Valsa, V. S. Ghole, S. S. Salvi : Inflammatory markers and experimental studies in occupational and environmental diseases - Bus drivers show higher levels of exhaled carbon monoxide, a marker of lung oxidative stress. Eur Respir J 2006; P3615.

·                     Salvi SS, D’Silva L, Chhowala S, Brashier B, Bal T, Gogtay JA. Use of Spirometry in clinical practice for Obstructive Lung Diseases in India. Chest 2005; 128(4): 248S.

·                     Brashier B, Jantikar A, Maganji M, Raghupathy A, Valsa S, Gokhale P, Mahadik P, Gogtay JA, Salvi SS. Addition of Formoterol to Tiotropium produces better FEV1 and FVC responses when measured over 24 hours following single-dose administration in subjects with moderate-to-severe COPD. Chest 2005; 128(4): 258S.

·                     Jantikar A, Brashier B, Raghupathy A, Vincent V, Bal T, Salvi SS. A single dose of tiotropium produces a significant improvement in 6-minute walk distance in severe COPD subjects. Eur Respir J 2005; 26: Suppl. 49.

·                     Brashier B, Londhe J, Jantikar A, Bal T, Salvi SS. Prevalence of obstructive lung diseases in 12,043 urban slum dwellers of Pune city, India. Eur Respir J 2005; 26: Suppl. 49, 592s.

·                     Brashier B, Bal T, Mahadik P, Gokhale P, Gogtay J, Salvi SS.
Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator therapeutic response as that administered by the Rotahaler in adults with chronic obstructive pulmonary disease. Eur Respir J 2005; 26: Suppl. 49, 125s.

·                     Salvi SS, Wagh AP, Bhutada U, Ghorpade SV, Tayade BO, Bal T, Brashier B. High prevalence and under-diagnosis of obstructive lung diseases in hospitalized patients in India. Eur Respir J 2005; 26: Suppl. 49, 594s.

·                     Ramnani A, Ghorpade SV, Brashier B, Bal T, Joshi DR, Gaikwad S, Salvi SS. Elevated levels of exhaled carbon monoxide in traffic policemen from Pune city. Eur Respir J 2005; 26: Suppl. 49, 386s.

·                    Jantikar A, Brashier B, Raghupathy A, Bal T, Mahadik P, Gokhale P, Gogtay J, Salvi SS. A pMDI formulation of levosalbutamol produces an equivalent bronchodilator response as racemic salbutamol at half the dose. Eur Respir J 2005; 26: Suppl. 49, 122s.

 

 

News
CRF at ERS 2016 London
7 of the 12 abstracts submitted were selected at t
CRF at ERS 2015 Amsterdam
9 of the 13 abstracts submitted were selected at t
Events
ICONIC 2016
Chest Research Foundation, Pun...
Programs management
     Programs management
Loading ...Loading ...